NOXXON Pharma N.V.: Noxxon Provides Results of Its 2022 Annual General Meeting of Shareholders

Noxxon Pharma to Become "TME Pharma" Regulatory News: NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX) (Paris:ALNOX), a biotechnology company focused on improving cancer treatments by targeting

Related Keywords

Paris ,France General ,France ,Netherlands ,Guillaume Van Renterghem ,Arthur Rouill ,Aram Mangasarian ,Bryan Jennings ,Pharmanv Euronext ,Merck Keytruda ,Cornelis Alexander Izeboud ,Maurizio Petitbon ,Linkedin ,Twitter ,Merck Sharp Dohme Corp ,Noxxon Pharma ,Euronext Growth Paris ,Euronext Growth ,Baker Tilly ,Merck Sharp Dohme ,Executive Officer ,Media Relations ,Noxxon ,Dharma ,Rovides ,Results ,022 ,Nnual ,Eneral ,Meeting ,Shareholders ,